The use of wearable ECG monitors should be explored as a strategy to prevent stroke, the researchers say.
ATAGI wants doctors to check for anticoagulation therapy or anaphylaxis history
Findings will reassure doctors that rivaroxaban is okay for patients with CHD and mild-to-moderate obesity, expert says.
Patients are missing out on timely review of their stroke risk in primary care, a study suggests.
The analysis in people with AF suggests a NOAC might be the better option for those at risk of osteoarthritis, authors say.
Emerging evidence suggests patients with AF who have a bleed should probably be investigated for malignancy, cardiologists warn.
A secondary trial analysis shows low-dose rivaroxaban and aspirin benefit high-risk patients with lower extremity PAD, authors say.
A leading cardiologist says an RCT is needed, but he is already anticoagulating hospitalised patients unless contraindicated.
Intervention to inform patients about reducing stroke risk falls short of what's needed, researchers say.
Chinese study found a composite outcome was significantly better in those on the therapy.